ISO 10993-1, Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing within a Risk Management Process, is the most widely used standard for assessing the biocompatibility of medical devices and materials, and provides a framework for determining the appropriate biocompatibility steps for planning a biological evaluation. Specific testing is dependent on the type of medical device or material and its intended use, and on the nature and duration of contact between the medical device and the body. According to the standard, an assessment for biological effects from the exposure of a medical device or material to human body can include testing such as cytotoxicity, sensitization, irritation or intracutaneous reactivity, systemic toxicity, subchronic toxicity, genotoxicity, implantation and haemocompatibility, etc.
Biocompatibility testing shall be conducted in compliance with Principles of Good Laboratory Practice (GLP) and/or ISO/IEC 17025.
TÜV SÜD laboratories offer a comprehensive range of GLP-compliant biocompatibility testing services according to the ISO 10993 series of standards, including biocompatibility studies and chemical-related testing services. In addition, TÜV SÜD Product Service’s industry specialists and clinical practitioners have extensive experience with all types of medical devices, and the compliance of regulatory requirements for medical devices in major medical device markets.